A New Outlook: Treatment Advances for Diabetic Eye Disease and Neovascular AMD

1-10 of 10

• 

  RestartResume

  Exploring the Latest Advances in the Treatment of Diabetic Eye Disease

  RestartResume

  Exploring the Latest Advances in the Treatment of Diabetic Eye Disease

  CME/CE Broadcast Replay

  Exploring the Latest Advances in the Treatment of Diabetic Eye Disease

  Jennifer I. Lim, MD; Nancy M. Holekamp, MD

  1.25 credits

  • 

    

    Jennifer I. Lim, MD

  • 

    

    Nancy M. Holekamp, MD

  • 

    

    Sunir J. Garg, MD, FACS, FASRS

  1.25 credits

• 

  RestartResume

  Achieving New Heights of Durability in Retina: What’s in Store for Retina Treatments and the Patients Who Need Them

  RestartResume

  Achieving New Heights of Durability in Retina: What’s in Store for Retina Treatments and the Patients Who Need Them

  CME/CE

  Achieving New Heights of Durability in Retina: What’s in Store for Retina Treatments and the Patients Who Need Them

  Christina Y. Weng, MD, MBA; Charles C. Wykoff, MD, PhD

  1.00 credit

  • 

    

    Christina Y. Weng, MD, MBA

  • 

    

    Charles C. Wykoff, MD, PhD

  • 

    

    Nancy M. Holekamp, MD

  • 

    

    Jeremy D. Wolfe, MD, MS

  1.00 credit

• 

  RestartResume

  Exploring the Suprachoroidal Space: Focus on RGX-314

  RestartResume

  Exploring the Suprachoroidal Space: Focus on RGX-314

  CME/CE Broadcast Replay

  Exploring the Suprachoroidal Space: Focus on RGX-314

  Charles C. Wykoff, MD, PhD; Nancy M. Holekamp, MD

  0.50 credits

  • 

    

    Charles C. Wykoff, MD, PhD

  • 

    

    Nancy M. Holekamp, MD

  0.50 credits

• 

  RestartResume

  Decision-Making Strategies for Optimal Outcomes

  RestartResume

  Decision-Making Strategies for Optimal Outcomes

  CME/CE Broadcast Replay

  Decision-Making Strategies for Optimal Outcomes

  W. Lloyd Clark, MD; Nancy M. Holekamp, MD

  0.25 credits

  • 

    

    W. Lloyd Clark, MD

  • 

    

    Nancy M. Holekamp, MD

  0.25 credits

• 

  RestartResume

  AMD: Time for a Change of Pace

  RestartResume

  AMD: Time for a Change of Pace

  CME/CE Broadcast Replay

  AMD: Time for a Change of Pace

  John W. Kitchens, MD; Nancy M. Holekamp, MD

  0.25 credits

  • 

    

    John W. Kitchens, MD

  • 

    

    Nancy M. Holekamp, MD

  0.25 credits

• 

  RestartResume

  Shedding Light on nAMD: The Latest Advances in Treating Neovascular Age-Related Macular Degeneration

  RestartResume

  Shedding Light on nAMD: The Latest Advances in Treating Neovascular Age-Related Macular Degeneration

  CME/CE Broadcast Replay

  Shedding Light on nAMD: The Latest Advances in Treating Neovascular Age-Related Macular Degeneration

  John W. Kitchens, MD; W. Lloyd Clark, MD

  1.50 credits

  • 

    

    John W. Kitchens, MD

  • 

    

    W. Lloyd Clark, MD

  • 

    

    Nancy M. Holekamp, MD

  1.50 credits

• 

  RestartResume

  Recalcitrant nAMD/DME: How Much Fluid Can We Tolerate?

  RestartResume

  Recalcitrant nAMD/DME: How Much Fluid Can We Tolerate?

  CME/CE Broadcast Replay

  Recalcitrant nAMD/DME: How Much Fluid Can We Tolerate?

  Nancy M. Holekamp, MD; Julia A. Haller, MD

  0.50 credits

  • 

    

    Nancy M. Holekamp, MD

  • 

    

    Julia A. Haller, MD

  0.50 credits

• 

  RestartResume

  Switching Therapies for Better Outcomes

  RestartResume

  Switching Therapies for Better Outcomes

  CME/CE Broadcast Replay

  Switching Therapies for Better Outcomes

  Maria H. Berrocal, MD; Nancy M. Holekamp, MD

  0.50 credits

  • 

    

    Maria H. Berrocal, MD

  • 

    

    Nancy M. Holekamp, MD

  0.50 credits

• 

  RestartResume

  Focus on PDS: Insertion Techniques and Patient Selection

  RestartResume

  Focus on PDS: Insertion Techniques and Patient Selection

  CME/CE Broadcast Replay

  Focus on PDS: Insertion Techniques and Patient Selection

  Nancy M. Holekamp, MD; Dante Pieramici, MD

  0.50 credits

  • 

    

    Nancy M. Holekamp, MD

  • 

    

    Dante Pieramici, MD

  0.50 credits

• 

  RestartResume

  Exploring a New Era in Retinal Disease Treatments

  RestartResume

  Exploring a New Era in Retinal Disease Treatments

  CME/CE

  Exploring a New Era in Retinal Disease Treatments

  Arshad M. Khanani, MD, MA; John W. Kitchens, MD

  1.00 credit

  • 

    

    Arshad M. Khanani, MD, MA

  • 

    

    John W. Kitchens, MD

  • 

    

    Jennifer I. Lim, MD

  • 

    

    Nancy M. Holekamp, MD

  1.00 credit